Development and evaluation of a chromatographic procedure for partial purification of substance P with quantitation by an enzyme immunoassy

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 3, 1998, Pages 303-307

  Fehder, William P ^a,b   Ho, Wen Zhe ^c,d   Campbell, Donald E ^a,c,d   Tourtellotte, Wallace W ^e   Michaels, Lisa ^a   Cutilli, Joann R ^c   Uvaydova, Marina ^c   Douglas, Steven D ^a,c,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c the Joseph Stokes Jr Research Institute   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUBSTANCE P;

ADULT; ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PLASMA; PRIORITY JOURNAL; PROTEIN PURIFICATION; QUANTITATIVE ASSAY; RADIOIMMUNOASSAY; SERUM;

EID: 0031859533     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.3.303-307.1998     Document Type: Article

References (27)

1. Arimura, A., G. Lundqvist, J. Rothman, R. Chang, R. Fernandez-Durango, R. Elde, D. Coy, C. Meyers, and A. Schally. 1978. Radioimmunoassay of somatostatin. Metabolism 27:1139-1144.
2. Azzari, C., M. Rossi, M. Resti, A. Caldini, L. Legra, L. Galli, E. Fico, and A. Vierucci. 1992. Imbalance in the levels of substance P and somatostatin in HIV positive children. Ped. Med. Chir. 14:577-581.
3. Bartho, L., and P. Holzer. 1985. Search for a physiological role of substance P in gastrointestinal motility. Neuroscienee 16:1 -32.
4. Chancellor-Freeland, C, G. Zhu, R. Kage, D. Beller, S. Leeman, and P. Black. 1995. Substance P and stress induced changes in macrophages. Ann. N. Y. Acad. Sci. 771:472-484.
5. Chang, M., and S. Leeman. 1971. Amino-acid sequence of substance P. Nature 232:86-87.
6. Euler, U. 1977. Historical notes, p. 1-3. In U. Euler and B. Pernow (ed.). Substance P. Raven Press. New York. N.Y.
7. Euler, U., and J. Gaddurn. 1931. An unidentified depressor substance in certain tissue extracts. J. Physiol. 72:74-87.
8. Fehder, W., J. Sachs, M. Uvaydova, and S. Douglas. 1997. Substance P as an immune modulator of anxiety. Neuroimmunomodulation 4:42-48.
9. Fernandez-Rodriguez, C., J. Prieto, J. Quiroga, J. Zozoya, A. Andrade, M. Nunez, B. Sangro, and J. Penas. 1995. Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion Hepatology 21:35-40.
10. Ho, W., J. Lai, X. Zhu, M. Uvaydova, and S. Douglas. 1997. Human monocytes and macrophages express substance P and neurokinin 1 receptor. J. Immunol. 159:5654-5660.
11. Hokfelt, T., O. Johansson, J. Kellerth, A. Ljungdahl, G. Nilsson, A. Nygards, and B. Pernow. 1977. Immunohistochemical distribution of substance P. p. 117-145. In U. Euler and B. Pernow (ed.). Substance P. Raven Press. New York, N.Y.
12. Lembeck, F., R. Gamse, and H. Juan. 1977. Substance P and sensory nerve endings, p. 169-181. In U. Euler and B. Pernow (ed.), Substance P. Raven Press, New York, N.Y.
13. Lotz, M., J. Vaughan, and D. Carson. 1998. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241: 1218-1221.
14. McGillrs, J., M. Mitsuhashi, and D. Payan. 1990. Immunomodulation by tachykinin neuropeptides. Ann. N. Y. Acad. Sci. 594:85-94.
15. Moore, T. 1984. Modification of lymphocyte traffic by vasoactive neurotransmitter substances. Immunology 52:511.
16. Payan, D. 1989. Neuropeptides and inflammation: the role of substance P. Annu. Rev. Med. 40:341-352.
17. Payan, D., D. Brewster, and E, Goetzl. 1983. Specific stimulation of human T lymphocytes by substance P. J. Immunol. 131:1613-1615.
18. Pernow, B. 1993. Opening address. Regul. Pept. 46:4-6.
19. Powell, D., P. Skrabanek, and D. Cannon. 1977. Substance P: radioimmunoassay studies, p. 35-40. In U. Euler and B. Pernow (ed.), Substance P. Raven Press, New York, N.Y.
20. Rameshwar, P., G. Doina, and P. Gascon. 1993. In vitro stimulatory effect of substance P on hematopoiesis. Blood 81:391-398.
21. Rameshwar, P., and P. Gascon. 1995. Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: potential autoregulatory role for these cytokines in SP receptor expression and induction. Blood 86:482-490.
22. Rissler, K. 1995. Sample preparation, high-performance liquid chromatographic separation and determination of substance P-related peptides. J. Chromatogr. B 665:233-270.
23. Rossi, M., M. Resti, C. Azzari, G. Calabri, M. DeMartino, L. Galli, R. Carbonella, and A. Vierucci. 1994. High levels of IgA in HIV-1-perinatally-infected children: antigen specificity and possible role of increased substance P plasma levels. Pediatr. Allergy Immunol. 5:240-243.
24. Sacerdote, P., M. Carrabba, A. Galante, R. Pisati, B. Manfredi, and A. Panerai. 1995. Plasma and synovial fluid interleukin-1. interlcukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal anti-inflammatory drugs indomethacin, dielofenac and naproxen, Inflammatory Res. 44:486-490.
25. Stanisz. A., D. Befus, and J. Bienenstock. 1986. Differential effects of vasoactive intestinal peptide, substan P, and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J. Immunol. 136:152-156.
26. Stanisz, A., R. Scicchitano, P. Dazin. J. Bienenstock, and D. Payan. 1987. Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. J. Immunol. 139:749-754.
27. Withrington, P. 1992. The actions of two sensory neuropeptides, substance P and calcitonin gene-related peptide, on the canine hepatic arterial and portal vascular beds. Br. J. Pharmacol. 107:296-302.